Columbia, S.C. â¢ South Carolinaâs highest court on Wednesday further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug.
In its ruling, the state Supreme Court ordered Janssen Pharmaceutica, Inc., to pay about $124 million â more than $200 million less than the original penalty amount.
In 2011, a trial court ordered the drug maker to pay $327 million, saying Janssen broke the law by downplaying to doctors the links between diabetes...
Share this post
← Back to Utah